We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.94B
AUM Growth
+$94.8M
Cap. Flow
-$283M
Cap. Flow %
-14.54%
Top 10 Hldgs %
40.52%
Holding
93
New
12
Increased
18
Reduced
22
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 19.55%
2 Consumer Discretionary 13.12%
3 Financials 7.95%
4 Real Estate 7.03%
5 Energy 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QVCGA
26
DELISTED
QVC Group Inc Series A
QVCGA
$22.4M 1.15%
19,160
+3,713
+24% +$4.39M
AWI icon
27
Armstrong World Industries
AWI
$6.86B
$21.3M 1.09%
379,585
+96,900
+34% +$5.4M
TVTX icon
28
Travere Therapeutics
TVTX
$5.33B
$20.7M 1.06%
2,322,457
+34,874
+2% +$410K
JPM icon
29
JPMorgan Chase
JPM
$939B
$19.7M 1.01%
326,581
-17,189
-5% -$1M
BRFS
30
DELISTED
BRF SA
BRFS
$19.2M 0.99%
807,520
-189,700
-19% -$4.77M
ALLY icon
31
Ally Financial
ALLY
$13.1B
$17.3M 0.89%
760,375
-40,000
-5% -$955K
DYAX
32
DELISTED
DYAX CORPORATION
DYAX
$16.8M 0.86%
1,656,300
-537,300
-24% -$5.2M
ANAC
33
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$15.2M 0.78%
620,803
-505,236
-45% -$10.3M
TSM icon
34
PUT
TSMC
TSM
$2.09T
$14.4M 0.74%
711,300
VIPS icon
35
Vipshop
VIPS
$6.84B
$13.3M 0.68%
+704,000
New +$14.5M
BLUE
36
DELISTED
bluebird bio
BLUE
$13.2M 0.68%
28,302
CASC
37
DELISTED
Cascadian Therapeutics, Inc.
CASC
$12.9M 0.66%
1,117,678
+179,528
+19% +$2.74M
CYTR
38
DELISTED
CytRx Corp
CYTR
$11.3M 0.58%
738,567
-31,416
-4% -$621K
THS
39
DELISTED
Treehouse Foods
THS
$10.7M 0.55%
+132,450
New +$10.5M
RYAM icon
40
Rayonier Advanced Materials
RYAM
$565M
$10.4M 0.54%
+316,500
New +$11.1M
NXEO
41
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$9.89M 0.51%
+1,000,000
New +$9.82M
JKS
42
JinkoSolar
JKS
$775M
$9.87M 0.51%
358,900
ARMH
43
PUT
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$9.62M 0.49%
220,100
JASO
44
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$8.8M 0.45%
951,900
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.57M 0.44%
507,184
ARRY
46
DELISTED
Array Biopharma Inc
ARRY
$8.54M 0.44%
2,391,200
+295,000
+14% +$1.16M
AGIO icon
47
Agios Pharmaceuticals
AGIO
$2.16B
$8.35M 0.43%
136,100
+7,000
+5% +$302K
ZX
48
DELISTED
China Zenix Auto Internatl Ltd
ZX
$8.34M 0.43%
6,074,805
MDVN
49
DELISTED
MEDIVATION, INC.
MDVN
$8.29M 0.43%
167,656
-167,800
-50% -$7.13M
ETFC
50
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$8.24M 0.42%
365,000

Similar funds

QVT Financial's Q3 2014 Portfolio in Review

As of Q3 2014, QVT Financial held 93 positions worth $1.94B, up 5.1% from $1.85B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

QVT Financial withdrew a net $283M in Q3 2014, closing 10 positions and reducing 22 holdings. Its most notable exit was PHH Corporation, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, QVT Financial opened a new position in Alibaba worth $31.1M.

  • QVT Financial's largest Q3 2014 buy was Alibaba: 350,000 shares worth $31.1M.
  • QVT Financial added most to PEREGRINE SEMICONDUCTOR CORP COM STK (DE) in Q3 2014, an estimated $19.7M increase.
  • QVT Financial's biggest Q3 2014 reduction was Achillion Pharmaceuticals, cutting an estimated $45.3M.
  • QVT Financial fully exited PHH Corporation in Q3 2014, selling an estimated $20M.
  • QVT Financial's ten largest holdings make up 41% of its $1.94B portfolio in Q3 2014.
  • QVT Financial opened 12 new positions and closed 10 in Q3 2014.
  • QVT Financial's portfolio value rose 5.1% quarter-over-quarter to $1.94B.

Based on QVT Financial's 13F filing for Q3 2014, filed 14 Nov 2014.